We also analyzed the post-transcriptional protein levels of Notch receptors and target gene products in CD8+ T cells purified from the pooled spleen and LN of control and 4T1HA tumor-bearing WT mice treated with bortezomib. This evidence concerns the gene CD8A and neoplasm.